TPD & Induced Proximity Summit Leaderboard
  • Sunday, July 26, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 661

Author

Pharma Journalist 8962 posts 0 comments

NEX China Takes the Express for Healthy Food Together with Natural Extract Enterprises

Feb 26, 2019
In recent years, big health has risen as a national policy of China with the introduction of the “Healthy China 2030” Planning Outline, and China has specified the new positioning of…
Read More...

Seize the Strategic Market of the Livestock Industry, and Build an Integrated Professional Platform…

Feb 26, 2019
Animal Health & Feed Zone of CPhI China 2019 to Build a New Benchmark for the Industry Size of the global veterinary drug market continues to grow as the market continues to…
Read More...

5 Leaders, 1 Panel: Microbiome Movement – Drug Development Summit

Feb 25, 2019
As the race for the first FDA-approved microbiome-based therapeutic continues, join the 4th Microbiome Movement – Drug Development Summit this June to hear directly from 5 key industry…
Read More...

Abbott and Novo Nordisk enter partnership to provide integrated digital solution to people with…

Feb 22, 2019
Abbott and Novo Nordisk announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital…
Read More...

Novo Nordisk receives FDA approval of ESPEROCT (turoctocog alfa pegol, N8-GP)

Feb 22, 2019
Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for ESPEROCT for the treatment of adults and children with…
Read More...

Xencor Announces Partial Clinical Hold on Phase 1 Study of XmAb14045

Feb 22, 2019
Xencor, Inc. announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its Phase 1 study of XmAb14045, a CD123 x CD3 bispecific antibody molecule…
Read More...

Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

Feb 22, 2019
Merck announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck’s patent application directed to its proxy-CRISPR technology. “This is…
Read More...

Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with Janssen

Feb 21, 2019
Morphic Therapeutic announced that it has entered into a research and development collaboration with Janssen Biotech, Inc. (Janssen) to discover and develop novel integrin therapeutics…
Read More...

SMi’s Pharma Microbiology West Coast 2019 chair and speakers announced

Feb 21, 2019
Pharmaceutical Microbiology West Coast is back after a successful launch event in 2018. This year the conference is taking place at the Hyatt Regency Mission Bay Hotel, CA, USA on June…
Read More...

QIAGEN partners with Ares Genetics to advance global fight against antibiotic-resistant pathogens

Feb 21, 2019
QIAGEN N.V. announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V., to develop innovative bioinformatics and assay solutions to accelerate research targeting the…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Bora to Manufacture GERD Drug for U.S. Phase 3 Trial
  • FDA Grants Fast Track Status to Lundbeck’s Narcolepsy Drug
  • Affinia Gene Therapy Wins FDA Orphan Drug Status for Rare Heart Disease
  • BeOne Invests $300 Million in U.S. Manufacturing Expansion
  • Kairos and Bayer Partner on Advanced Prostate Cancer Study

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.